March 14-17, 2022
Hilton Tampa Downtown
Tampa, Florida

Conference Cochairs

Christina Curtis, Stanford University, Stanford, California
James DeGregori, University of Colorado, Aurora, Colorado
Marco Gerlinger, The Institute of Cancer Research, London, United Kingdom
Robert Gillies, Moffitt Cancer Center, Tampa, Florida
Andriy Marusyk, Moffitt Cancer Center, Tampa, Florida

Please note that this meeting will take place as an in-person event in Tampa and will not live-stream content for virtual participation. The meeting content will be captured and made available as an on-demand program after the meting. Please see the Registration page for details.

It is becoming increasingly well appreciated that cancers are complex and dynamic ecosystems that evolve in response to selection pressures from their environment. The aim of this conference is to move away from the simplistic view of cancer evolution as a merely genetic phenomenon and to discuss instead how microenvironmental, immune, genetic and epigenetic heterogeneity interact to influence cancer progression and therapy success or failure. By promoting the exchange of novel ideas and information between basic scientists, physicians, and other health professionals, this conference will enhance the understanding of cancer evolution and make progress toward improved treatments.

Lead supporter

AbbVie 

Professional educational grants

Pfizer

#AACRevol22